Skip to main content
. Author manuscript; available in PMC: 2014 Apr 21.
Published in final edited form as: J Immunol. 2008 Oct 1;181(7):5001–5007. doi: 10.4049/jimmunol.181.7.5001

Table I.

Clinical characteristics mean (SEM)a

Asthma (GINAa
treatment step I = 4,
II–IV = 5, V = 3)		 COPD Controls
Number 12 11 18
Gender male/female 5/7 7/4 13/5
Age (yrs) 47 (6) 65 (12) 60 (13)
FEV1 (liters) 2.6 (0.3) 1.68 (0.12) 2.5 (0.11)
FEV1% predicted 82.4 (9.8)% 61 (3) 85 (4)
FEV1/FVC (%) 71.9 (5.3) 59 (3) 79 (2)
a

GINA, Global Initiative for Asthma.